Active Funding Opportunities and Notices for NICHD
NICHD publishes and participates in various notices of funding opportunities (NOFOs) and NIH Guide Notices (NOTs) to support research and training activities.
NOTs and Active NOFOs for NICHD
Please note: the following are sorted by date, from most recent to older. Select a table heading to change how to sort the information.
| Number | Exp. Date | Activity Code(s) | Title |
|---|---|---|---|
| NOT-HD-23-004 | January 1, 2028 | Notice of Clarification for the Research Scope in RFA-HD-24-002 "Development of Novel Nonsteroidal Contraceptive Methods (R61/R33 - Clinical Trial Not Allowed)" | |
| PAR-23-112 | January 8, 2026 | R01 | Addressing the Impact of Structural Racism and Discrimination on Minority Health and Health Disparities (R01 - Clinical Trial Optional) |
| PAR-23-074 | January 8, 2026 | R01 | In-Depth Phenotyping and Research Using IMPC-Generated Knockout Mouse Strains Exhibiting Embryonic or Perinatal Lethality or Subviability (R01 Clinical Trial Not Allowed) |
| PAR-22-261 | November 17, 2025 | R03 | Archiving and Documenting Child Health and Human Development Data Sets (R03 Clinical Trial Not Allowed) |
| NOT-MH-23-115 | July 15, 2026 | R01,R24 | Notice of Special Interest (NOSI): BRAIN Initiative: Developing Data Archive, Informatics Tools and Data Standards for Brain Behavior Quantification and Synchronization (BBQS) |
| PAR-23-075 | January 8, 2026 | R03 | Small Research Grants for Analyses of Gabriella Miller Kids First Pediatric Research Data (R03 Clinical Trial Not Allowed) |
| NOT-OD-23-039 | February 5, 2026 | R01,R34,R21,U24,R61/R33,UG3/UH3 | Notice of Special Interest (NOSI): Firearm Injury and Mortality Prevention Research |
| PAR-23-067 | January 8, 2026 | R21 | Development of Animal Models and Related Biological Materials for Down Syndrome Research (R21 Clinical Trials Not Allowed) |
| NOT-OD-23-031 | October 1, 2025 | 333 | Notice of Special Interest: Administrative Supplements to Promote Research Continuity and Retention of NIH Mentored Career Development (K) Award Recipients and Scholars |
| NOT-OD-23-032 | October 1, 2025 | 333 | Notice of Special Interest (NOSI): Administrative Supplement for Continuity of Biomedical and Behavioral Research Among First-Time Recipients of NIH Research Project Grant Awards |
| PAR-23-037 | May 8, 2026 | U01 | Multisite Clinical Research: Leveraging Network Infrastructure to Advance Research for Women, Children, Pregnant and Lactating Individuals, and Persons with Disabilities (U01 Clinical Trial Optional) |
| NOT-HD-22-054 | January 1, 2028 | Request for Information (RFI): Developing Strategies to Strengthen Research on Stillbirth Prevention | |
| NOT-EB-22-011 | January 1, 2028 | Notice of Extension of the Expiration Date of PAR-20-169, "National Centers for Biomedical Imaging and Bioengineering (NCBIB) (P41 Clinical Trials Optional)" | |
| NOT-HD-22-051 | January 1, 2028 | Notice of NICHD Participation in PAR-22-243, "Bioengineering Research Grants (BRG) (R01 Clinical Trial Optional)" | |
| NOT-HD-22-053 | January 1, 2028 | Notice of NICHD Participation in RFA-OD-22-015, "Galvanizing Health Equity Through Novel and Diverse Educational Resources (GENDER) Research Education (R25 Clinical Trial Not Allowed) | |
| NOT-HD-22-050 | January 1, 2028 | Notice of NICHD Participation in PAR-22-242, "Bioengineering Research Grants (BRG) (R01 Clinical Trial Not Allowed)" | |
| PAR-22-247 | May 26, 2025 | R24 | Development of Animal Models and Related Biological Materials for Down Syndrome Research (R24 Clinical Trials Not-Allowed) |
| NOT-NR-23-001 | January 1, 2028 | NOTICE OF NINR TECHNICAL ASSISTANCE WEBINAR FOR RFA-NR-23-001 | |
| NOT-AI-22-072 | September 8, 2025 | R01,R21 | Notice of Special Interest (NOSI): Opportunities for HIV Cure Interventions at the Time of ART Initiation |
| NOT-HD-22-047 | January 1, 2028 | Notice of Training and REDCap Demonstration for the Implementation of NICHD's CDE Recommendations for COVID-19 Research in Pediatric, Pregnant, and Lactating Populations Published Through the NIEHS Disaster Research Response (DR2) Portal |
BACK TO TOP